A Phase II Study To Evaluate the Efficacy And Safety Of HRS-1301 In Participants With Dyslipidemia

Abroad (travel likely)RecruitingPHASE2

Conditions

Hyperlipidemia

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

The 2nd Affiliated Hospital of Harbin, Harbin, Heilongjiang, China
Contact: Principal Investigator (Bo Yu)

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study of HRS-1301 Tablets in Healthy Subjects and Those With Impaired Kidney Function

Hyperlipidemias

Abroad (travel likely)RecruitingPHASE1

Chengdu, China

Whole Grain Job's Tear, Muscle Health, Blood Glucose and Lipid Level

Sarcopenia · Frailty · Hyperglycemia

Abroad (travel likely)RecruitingPHASE2

Taipei, Taiwan

IBI306 Monotherapy in Non-Familial Hypercholesterolemia and Mixed Hyperlipidemia

Non-Familial Hypercholesterolemia and Mixed Hyperlipidemia

Abroad (travel likely)RecruitingPHASE3

Beijing, China

A Study to Evaluate the Safety, Efficacy of SYH2053 as Monotherapy in Chinese Participants With Non-familial Hypercholesterolemia or Mixed Hyperlipidemia

Non-familial Hypercholesterolemia and Mixed Hyperlipidemia

Abroad (travel likely)RecruitingPHASE3

Beijing, China · Beijing, China